Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Fmc Agricultural Solutions A/S currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These filings are assigned to 3 distinct examiners, indicating a distributed prosecution environment. This structure prevents the company's progress from being stalled by the views of a specific official and allows for a variety of technical perspectives to be incorporated into the portfolio. Such a strategy is beneficial for protecting complex biological innovations where different examiners may have different interpretations of the prior art and claim scope.
The company is active in distinct art units, reflecting a diverse set of technical focuses within its biotechnology innovations. SAWYER, JENNIFER C, is the busiest examiner, currently overseeing 1 pending office action. The diverse examiner assignments suggest that the company is pursuing several independent technical advancements simultaneously. Practitioners should carefully coordinate the responses across these different matters to maintain consistency in the company's technical disclosures and to ensure that all legal positions are aligned across the portfolio to achieve a successful outcome.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (33%) |
| Double-patenting + other | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SAWYER, JENNIFER C | 1 | 68.4% | -8.2% |
| MCKNIGHT, CIARA A | 1 | 61.5% | +40.3% |
| ROBINSON, HOPE A | 1 | 67.7% | +43.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18570271 | METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS | MCKNIGHT, CIARA A | — |
| 17783955 | Yeast cells and methods for production of E8,E10-dodecadienyl coenzyme A, codlemone and derivatives thereof | ROBINSON, HOPE A | — |
| Art Unit | Apps |
|---|---|
| 1691 | 1 |
| 1656 | 1 |
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18293550 | METHOD FOR PRODUCING FATTY ALDEHYDES AND DERIVATIVES THEREOF | SAWYER, JENNIFER C | 1691 | §103§112DPOther | Non-Final OA | — | Pending | Jan 30, 2024 |
| 18570271 | METHODS AND YEAST CELLS FOR PRODUCTION OF DESATURATED COMPOUNDS | MCKNIGHT, CIARA A | 1656 | §103§112DP | Non-Final OA | — | Pending | Dec 14, 2023 |
| 17783955 | Yeast cells and methods for production of E8,E10-dodecadienyl coenzyme A, codlemone and derivatives thereof | ROBINSON, HOPE A | 1652 | §112 | Non-Final OA | — | Pending | Jun 09, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialFmc Agricultural Solutions A/S has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Jennifer C Sawyer has the most, with 1 of Fmc Agricultural Solutions A/S's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
